Therapy with omalizumab: evaluation of effectiveness and safety in 27 patients with severe uncontrolled asthma

被引：0
|
作者：
Caiaffa, M. [1 ]
De Serio, A. [1 ]
Bellotti, A. [1 ]
Rucco, A. [2 ]
Lotti, A. [2 ]
Loconte, F. [2 ]
Kourtis, G. [2 ]
Macchia, L. [2 ]
机构：
[1] Univ Foggia, Dept Allergol & Clin Immunol, Foggia, Italy
[2] Univ Bari, Dept Allergol & Clin Immunol, Bari, Italy
来源：
ALLERGY | 2009年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
786
引用
收藏
页码：307 / 307
页数：1
相关论文
共 50 条
  • [41] Long-term "real-life" safety of omalizumab in patients with severe uncontrolled asthma: A nine-year study
    Di Bona, Danilo
    Fiorino, Irene
    Taurino, Marialuisa
    Frisenda, Flavia
    Minenna, Elena
    Pasculli, Carlo
    Kourtis, Georgios
    Rucco, Anna Simona
    Nico, Andrea
    Albanesi, Marcello
    Giliberti, Lucia
    D'Elia, Luciana
    Caiaffa, Maria Filomena
    Macchia, Luigi
    RESPIRATORY MEDICINE, 2017, 130 : 55 - 60
  • [42] The "real-world" effectiveness and safety of omalizumab in patients with uncontrolled persistent allergic asthma in Slovakia: a subgroup analysis of the eXpeRience study
    Siracka, Simona
    Tinkova, Lenka Dziva
    Hochmuth, Ludek
    Lescisinova, Helena
    Hrubisko, Martin
    Dostalova, Katarina
    Jesenak, Milos
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2023, 40 (01): : 134 - 141
  • [43] THE SAFETY OF OMALIZUMAB THERAPY IN A PATIENT WITH SEVERE PERSISTENT ALLERGIC ASTHMA AND HEPATITIS C
    Antonicelli, Leonardo
    Stagnozzi, Giorgia
    Giuliodoro, Simona
    Abbruzzetti, Alessandra
    Massaccesi, Chiara
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2009, 103 (03) : 269 - 270
  • [44] ASSESSMENT OF OMALIZUMAB SAFETY IN PATIENTS WITH SEVERE PERSISTENT ALLERGIC ASTHMA THREE MONTHS AFTER INITIATION OF THERAPY
    Al Kassar, Y.
    El-Sameed, Y.
    Hassan, A.
    Djazmati, W.
    RESPIROLOGY, 2012, 17 : 8 - 8
  • [45] PHARMACOECONOMIC ANALYSIS OF TREATMENT OF CHILDREN WITH SEVERE UNCONTROLLED ASTHMA WITH OMALIZUMAB IN RUSSIA
    Kolbin, A.
    Namazova-Baranova, L.
    Vishneva, E.
    Frolov, M.
    Galankin, T.
    Alekseeva, A.
    Dobrynina, E.
    VALUE IN HEALTH, 2016, 19 (07) : A555 - A555
  • [46] Effectiveness and safety of biological therapy in patients with severe asthma in a real clinical practice
    Sergeeva, Galina R.
    V. Emelyanov, Alexander
    TERAPEVTICHESKII ARKHIV, 2024, 96 (03) : 240 - 245
  • [47] Cost-effectiveness of tiotropium versus omalizumab for uncontrolled allergic asthma
    Buendia, Jefferson Antonio
    Guerrero Patino, Diana
    Cossio-Giraldo, Yamith Eutimio
    JOURNAL OF ASTHMA, 2022, 59 (10) : 2016 - 2023
  • [48] Omalizumab in children with severe uncontrolled asthma: 2 years' clinical experience
    Piquer Gibert, M.
    Dominguez Sanchez, O.
    Giner Munoz, M.
    Plaza Martin, A.
    Martin Mateos, M.
    Lozano, J.
    Lozano, J.
    Alvaro Lozano, M.
    Alvaro Lozano, M.
    ALLERGY, 2010, 65 : 530 - 530
  • [49] Indirect comparison of bronchial thermoplasty versus omalizumab for uncontrolled severe asthma
    Niven, Robert M.
    Simmonds, Michael R.
    Cangelosi, Michael J.
    Tilden, Dominic P.
    Cottrell, Suzanne
    Shargill, Narinder S.
    JOURNAL OF ASTHMA, 2018, 55 (04) : 443 - 451
  • [50] Omalizumab in severe uncontrolled asthma: a 2-year clinical experience
    Vennera, M.
    Valero, A.
    Bartra, J.
    Munoz, R.
    Mora, R.
    Picado, C.
    ALLERGY, 2009, 64 : 306 - 306
12345